Biotech Pioneer Submits Regulation A+ Filing With For Up To $50 Million Initial Public Offering Post author:Sam Post published:September 6, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like GlaxoSmithKline to Shift Neuro R&D Out of China to Philadelphia Research Hub August 3, 2017 Almirall Discontinues R&D for Two Drugs in the U.S. September 28, 2017 4 Biotechs Facing Do-or-Die Catalysts in December December 5, 2017